Cortsworth said Rhettsivir seemed to shorten hospital stay
Australian Deputy Chief Medical Officer Nick Cozworth warned that Australia's first drug to be approved for the new crown was not a "panacea "(silver bullet).
He said :" Rhettsivir can prevent Coronavirus from reproducing further in vivo, but it is important to note that none of the drugs available is a "panacea ". No significant results have been reported in international medical trials, but some of these findings suggest that Rhettsivir may be effective in patients with moderate to severe disease. "
The drug appears to shorten the length of hospital stay, Coatsworth said. But he said :" We do not know whether it has a decisive impact on death rates. "While Rhett Sivir has been sought after, it has proved that the weapon that really works to contain Coronavirus is Australia's superb nurse and doctors ," Coatsworth said. "Approving the use of Rhett Sivir is certainly good news, but skilled doctors and nurse are the best weapons we have ," he said. "There is concern that Australia may not have access to adequate supplies of drugs after the United States acquired most of the global inventory of Redsea in June. Brett Sutton (Brett Sutton), Virginia's chief medical officer, said the U.S. had bought almost all its inventory for the next three months. But cozworth said the drug's manufacturer, jilide (Gilead), had donated a large number of drugs to australia's national medical inventory.
He said he was confident the drugs would be enough for the next few weeks until he could buy more supplies.
Today, Rhett Sivir has been approved for use in its producer countries, the United States, as well as India, Japan and the European Union. Preliminary tests have shown that radixivir has been able to improve the condition of hospitalized patients with severe new crowns, which means that the use of the drug can reduce the stress on the medical system. Gillied is the only company allowed to produce Rhett Sivir, with U.S. purchases equal to 100 percent of Geely's July output ,90 percent of its August output, and 90 percent of its September output.
